Hip Osteoarthritis Pain Medicine is to relieve pain, and cannot slow the progress of osteoarthritis.

Scope of the Report:

The worldwide market for Hip Osteoarthritis Pain Medicine is expected to grow at a CAGR of roughly 5.6% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Hip Osteoarthritis Pain Medicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Pfizer

Johnson & Johnson

GlaxoSmithKline

Bayer

Eli Lilly

Novartis

Sanofi

Horizon Pharma

Abbott

Mylan

Daiichi Sankyo

TEVA

Almatica Pharma

Astellas Pharma

Tide Pharmaceutical

Iroko Pharmaceuticals

Hengrui Pharmaceutical

Abiogen Pharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oral

Injection

External

Market Segment by Applications, can be divided into

Medical Care

Personal Care

There are 15 Chapters to deeply display the global Hip Osteoarthritis Pain Medicine market.

Chapter 1, to describe Hip Osteoarthritis Pain Medicine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hip Osteoarthritis Pain Medicine, with sales, revenue, and price of Hip Osteoarthritis Pain Medicine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hip Osteoarthritis Pain Medicine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hip Osteoarthritis Pain Medicine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hip Osteoarthritis Pain Medicine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Hip Osteoarthritis Pain Medicine Introduction

1.2 Market Analysis by Type

1.2.1 Oral

1.2.2 Injection

1.2.3 External

1.3 Market Analysis by Applications

1.3.1 Medical Care

1.3.2 Personal Care

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Johnson & Johnson

2.2.1 Business Overview

2.2.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Johnson & Johnson Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline

2.3.1 Business Overview

2.3.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Bayer

2.4.1 Business Overview

2.4.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bayer Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Eli Lilly

2.5.1 Business Overview

2.5.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Eli Lilly Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Novartis

2.6.1 Business Overview

2.6.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Novartis Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Sanofi

2.7.1 Business Overview

2.7.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Sanofi Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Horizon Pharma

2.8.1 Business Overview

2.8.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Horizon Pharma Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Abbott

2.9.1 Business Overview

2.9.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Abbott Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Mylan

2.10.1 Business Overview

2.10.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Mylan Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Daiichi Sankyo

2.11.1 Business Overview

2.11.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 TEVA

2.12.1 Business Overview

2.12.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 TEVA Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Almatica Pharma

2.13.1 Business Overview

2.13.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Almatica Pharma Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 Astellas Pharma

2.14.1 Business Overview

2.14.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Astellas Pharma Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Tide Pharmaceutical

2.15.1 Business Overview

2.15.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Iroko Pharmaceuticals

2.16.1 Business Overview

2.16.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.17 Hengrui Pharmaceutical

2.17.1 Business Overview

2.17.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.18 Abiogen Pharma

2.18.1 Business Overview

2.18.2 Hip Osteoarthritis Pain Medicine Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Abiogen Pharma Hip Osteoarthritis Pain Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Hip Osteoarthritis Pain Medicine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Hip Osteoarthritis Pain Medicine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Hip Osteoarthritis Pain Medicine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Hip Osteoarthritis Pain Medicine Manufacturer Market Share in 2017

3.3.2 Top 6 Hip Osteoarthritis Pain Medicine Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Hip Osteoarthritis Pain Medicine Market Analysis by Regions

4.1 Global Hip Osteoarthritis Pain Medicine Sales, Revenue and Market Share by Regions

4.1.1 Global Hip Osteoarthritis Pain Medicine Sales and Market Share by Regions (2013-2018)

4.1.2 Global Hip Osteoarthritis Pain Medicine Revenue and Market Share by Regions (2013-2018)

4.2 North America Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

4.3 Europe Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

4.5 South America Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

5 North America Hip Osteoarthritis Pain Medicine by Countries

5.1 North America Hip Osteoarthritis Pain Medicine Sales, Revenue and Market Share by Countries

5.1.1 North America Hip Osteoarthritis Pain Medicine Sales and Market Share by Countries (2013-2018)

5.1.2 North America Hip Osteoarthritis Pain Medicine Revenue and Market Share by Countries (2013-2018)

5.2 United States Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

5.3 Canada Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

5.4 Mexico Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

6 Europe Hip Osteoarthritis Pain Medicine by Countries

6.1 Europe Hip Osteoarthritis Pain Medicine Sales, Revenue and Market Share by Countries

6.1.1 Europe Hip Osteoarthritis Pain Medicine Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Hip Osteoarthritis Pain Medicine Revenue and Market Share by Countries (2013-2018)

6.2 Germany Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

6.3 UK Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

6.4 France Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

6.5 Russia Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

6.6 Italy Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

7 Asia-Pacific Hip Osteoarthritis Pain Medicine by Countries

7.1 Asia-Pacific Hip Osteoarthritis Pain Medicine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Hip Osteoarthritis Pain Medicine Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Hip Osteoarthritis Pain Medicine Revenue and Market Share by Countries (2013-2018)

7.2 China Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

7.3 Japan Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

7.4 Korea Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

7.5 India Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

8 South America Hip Osteoarthritis Pain Medicine by Countries

8.1 South America Hip Osteoarthritis Pain Medicine Sales, Revenue and Market Share by Countries

8.1.1 South America Hip Osteoarthritis Pain Medicine Sales and Market Share by Countries (2013-2018)

8.1.2 South America Hip Osteoarthritis Pain Medicine Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

8.3 Argentina Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

8.4 Colombia Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

9 Middle East and Africa Hip Osteoarthritis Pain Medicine by Countries

9.1 Middle East and Africa Hip Osteoarthritis Pain Medicine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Hip Osteoarthritis Pain Medicine Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Hip Osteoarthritis Pain Medicine Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

9.3 UAE Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

9.4 Egypt Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

9.5 Nigeria Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

9.6 South Africa Hip Osteoarthritis Pain Medicine Sales and Growth Rate (2013-2018)

10 Global Hip Osteoarthritis Pain Medicine Market Segment by Type

10.1 Global Hip Osteoarthritis Pain Medicine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Hip Osteoarthritis Pain Medicine Sales and Market Share by Type (2013-2018)

10.1.2 Global Hip Osteoarthritis Pain Medicine Revenue and Market Share by Type (2013-2018)

10.2 Oral Sales Growth and Price

10.2.1 Global Oral Sales Growth (2013-2018)

10.2.2 Global Oral Price (2013-2018)

10.3 Injection Sales Growth and Price

10.3.1 Global Injection Sales Growth (2013-2018)

10.3.2 Global Injection Price (2013-2018)

10.4 External Sales Growth and Price

10.4.1 Global External Sales Growth (2013-2018)

10.4.2 Global External Price (2013-2018)

11 Global Hip Osteoarthritis Pain Medicine Market Segment by Application

11.1 Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2013-2018)

11.2 Medical Care Sales Growth (2013-2018)

11.3 Personal Care Sales Growth (2013-2018)

12 Hip Osteoarthritis Pain Medicine Market Forecast (2018-2023)

12.1 Global Hip Osteoarthritis Pain Medicine Sales, Revenue and Growth Rate (2018-2023)

12.2 Hip Osteoarthritis Pain Medicine Market Forecast by Regions (2018-2023)

12.2.1 North America Hip Osteoarthritis Pain Medicine Market Forecast (2018-2023)

12.2.2 Europe Hip Osteoarthritis Pain Medicine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Hip Osteoarthritis Pain Medicine Market Forecast (2018-2023)

12.2.4 South America Hip Osteoarthritis Pain Medicine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Hip Osteoarthritis Pain Medicine Market Forecast (2018-2023)

12.3 Hip Osteoarthritis Pain Medicine Market Forecast by Type (2018-2023)

12.3.1 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Type (2018-2023)

12.3.2 Global Hip Osteoarthritis Pain Medicine Market Share Forecast by Type (2018-2023)

12.4 Hip Osteoarthritis Pain Medicine Market Forecast by Application (2018-2023)

12.4.1 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Application (2018-2023)

12.4.2 Global Hip Osteoarthritis Pain Medicine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Hip Osteoarthritis Pain Medicine Picture

Table Product Specifications of Hip Osteoarthritis Pain Medicine

Figure Global Sales Market Share of Hip Osteoarthritis Pain